The HI-STEM Founding Team celebrates ten years of successful cooperation: Friedrich von Bohlen, Managing Director dievini Hopp BioTech Holding, Josef Puchta, Administrative Director DKFZ, Heike Bauer, Head Dietmar Hopp Stiftung, Dietmar Hopp Founder and Managing Director Dietmar Hopp Foundation, Andreas Trumpp, HI-STEM Managing Director, Michael Baumann, DKFZ Managing Director, Christof Hettich, Co-Managing Director dievini Hopp BioTech Holding (from left to right) | © Stefan Hebling
The HI-STEM Founding Team celebrates ten years of successful cooperation: Friedrich von Bohlen, Managing Director dievini Hopp BioTech Holding, Josef Puchta, Administrative Director DKFZ, Heike Bauer, Head Dietmar Hopp Stiftung, Dietmar Hopp Founder and Managing Director Dietmar Hopp Foundation, Andreas Trumpp, HI-STEM Managing Director, Michael Baumann, DKFZ Managing Director, Christof Hettich, Co-Managing Director dievini Hopp BioTech Holding (from left to right) | © Stefan Hebling

Ten years ago, HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine, started its work within the newly renovated labs of the German Cancer Research Center (DKFZ). On the occasion of this anniversary, the founders have drawn a balance: Researchers at HI-STEM could proof for multiple cancer types how stem cells play a role during initiation, progression and therapy resistance of malignant tumors. The work of HI-STEM, which has been published in high-profile publications, has indicated new approaches for a more targeted and effective treatment of this devastating diseases.

In 2008, the DKFZ and the Dietmar Hopp Foundation joined forces to establish HI-STEM as a non-for-profit public private partnership. This concept of collaboration between academic research and a private organization was at that time highly innovative. “We are very grateful to all who contributed to the foundation of HI-STEM ten years ago. Especially we want to thank Dietmar Hopp and his foundation as well as the Management Board of the DKFZ for their extraordinary and sustained support.” says HI-STEM Managing Director Andreas Trumpp, who also acts as division head at the German Cancer Research Center.

Further Information: